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ABSTRACT
We have developed a high-throughput protein
expression and interaction analysis platform that
combines cDNA phage display library selection
and massive gene sequencing using the 454
platform. A phage display library of open reading
frame (ORF) fragments was created from mRNA
derived from different tissues. This was used to
study the interaction network of the enzyme
transglutaminase 2 (TG2), a multifunctional enzyme
involved in the regulation of cell growth, differentia-
tion and apoptosis, associated with many different
pathologies. After two rounds of panning with TG2
we assayed the frequency of ORFs within the
selected phage population using 454 sequencing.
Ranking and analysis of more than 120000
sequences allowed us to identify several potential
interactors, which were subsequently confirmed in
functional assays. Within the identified clones, three
had been previously described as interacting
proteins (fibronectin, SMOC1 and GSTO2), while
all the others were new. When compared with
standard systems, such as microtiter enzyme-linked
immunosorbant assay, the method described here
is dramatically faster and yields far more informa-
tion about the interaction under study, allowing
better characterization of complex systems. For
example, in the case of fibronectin, it was possible
to identify the specific domains involved in the
interaction.
INTRODUCTION
Generally used methods to screen for protein–protein
interactions include tandem aﬃnity puriﬁcation followed
by mass spectrometry, yeast two hybrid system (Y2H),
protein complementation assays (PCA), ribosome/RNA
display (1–3) and phage display (4). With the exception
of tandem aﬃnity puriﬁcation, which directly assesses
proteins that interact with a particular target protein,
each of these assays involve time consuming picking and
assessment of individual clones after a selection or screen-
ing procedure. Consequently although thousands of
clones, or even more, may be generated in any of these
screening/selection procedures, the number actually
analyzed is usually limited to the number of wells on a
microtiter plate (96 or multiples thereof) and is therefore
signiﬁcantly smaller. Whether such manual random
picking strategies can identify all possible interactions
with a given bait-protein depends upon the protein
under study and cannot be predicted in advance. In par-
ticular, random picking is not successful if a large number
of diﬀerent binders are expected, such as occurs in the
screening of a protein with multiple interaction partners,
or a few clones are over-represented during the selection
process. A novel approach in which the number of
screened clones could be increased by several orders of
magnitude would therefore represent a major advance
in the ﬁeld.
In this article we applied a deep DNA sequencing
strategy, ﬁrst to the characterization of a cDNA phage
display library, and subsequently to the identiﬁcation
of the proteins interacting with the enzyme tissue trans-
glutaminase 2 (TG2), a molecule of increasing interest, in
that its biological activity has been associated with a
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purpose was to follow the progress of the selection and
analyze the whole output in a comprehensive manner,
rather than performing random clone picking and
enzyme-linked immunosorbant assay (ELISA). Among
the available deep-sequencing systems, 454 pyro-
sequencing (6) is the only one that is suitable for this
approach due to the longer read length that can be
achieved: up to 450bp per sequence and a total of over
1 million reads per run with the recently introduced
Titanium system.
Phage display has been widely used to select antibodies
or short peptides from libraries, however, phage display
with cDNA libraries has been rarely used due to the large
number of non-functional clones present. This problem
has been recently addressed by the concept of ﬁltering
DNA for the presence of open reading frames (ORFs),
and a number of diﬀerent approaches have been taken
(7–11). In this manuscript, the cloning procedure was
based on pPAO2, a display system developed by us
(12,13) that directly ﬁlters DNA for ORFs within a
phage display context, in such a way that they are
amenable to subsequent selection or screening. In this
vector, DNA fragments are cloned upstream of the
b-lactamase gene and clones are selected for ampicillin
resistance. After this step, referred to as ORF ﬁltering,
the b-lactamase gene is removed by Cre-lox mediated
recombination and an in-frame ORF-g3p fusion product
is displayed on the phage surface. This vector has a strong
bias for ORFs corresponding to real genes rather than
ORFs of no biological signiﬁcance, indicating that the
lactamase gene functions as a folding reporter (14), akin
to those previously described using either GFP (15),
chloramphenicol resistance (16) or beta-galactosidase
(17). However, unlike these other systems, functional
analysis based on binding activity can also be subse-
quently carried out. As a target protein we used TG2, a
human enzyme showing a number of diﬀerent biological
functions. In the cytosol, it is involved in protein
cross-linking (18), signaling activity (19), protein disulﬁde
isomerase activity (20), and even activity as a protein
kinase (21). The protein is also found extracellularly
where it is involved in the maintenance of tissue stability,
cell adhesion and migration. Notably, aberrant functions
of TG2 have been associated with a number of patholog-
ical conditions, including neurodegenerative diseases and
several autoimmune diseases as diabetes, multiple sclerosis
and rheumatoid arthritis (5). Antibodies against TG2 are
used routinely to diagnose celiac disease. The approach
described here was used to identify a set of TG2
interactors. Some of these had been previously described,
while others are novel. Furthermore, the sequences of the
selected cDNA fragments allowed us to identify the
speciﬁc domains partaking in the interactions with TG2.
MATERIALS AND METHODS
RNA and cDNA fragments preparation
Three diﬀerent mRNA sources were used to create the
libraries: human colon carcinoma (HCC); human lung
ﬁbroblasts (HF) and human pancreatic islets (HPI). The
HCC sample was obtained by pooling roughly equivalent
amounts of polyA+ RNA obtained from the following
cell lines: SW 620, CaCo-2, W.Dr C2Bbe1, CoLo 320 DM,
HCT 116, HT29, SW 480. The HF sample was obtained
by pooling RNA from Wi 38 and HFL 1. The HPI sample
was obtained by purifying polyA+ RNA from a few
thousand human pancreatic islets. For each sample,
mRNA (1mg HCC or 1mg HF or 300ng HPI) was
mildly fragmented by heating for 6min at 95 C prior to
reverse transcription with random hexamers. The
single-stranded cDNA was normalized individually with
a corresponding mRNA (3mg of either HCC or HF
samples and 900ng of HPI sample polyA+ RNA)
according to Carninci et al. (22). The normalized cDNA
was depleted of poly-dT tails by hybridization (3h at
37 C) with biotinylated poly-dA and separation on
streptavidin magnetic beads as described before (22).
The unbound material was recovered, puriﬁed on
Millipore Microcone PCR ﬁlter (UFC7PCR50) and used
to build the libraries. The directional cloning of the
random cDNA fragments in the correct sense orientation
was based on a proprietary method developed by Quark
Pharmaceuticals Inc (23). Asymmetric adapters (contain-
ing BssHII and NheI restriction sites for further cloning)
were ligated to the single-stranded cDNA, the cDNA was
ampliﬁed for 15 cycles with adapter speciﬁc primers,
separated from short DNA fragments by gravity ﬂow gel
ﬁltration on a Chroma Spin—400 column (BD Clontech),
reampliﬁed for an additional 13 cycles and 100–600bp
fragments were puriﬁed on GeneClean Turbo
(Q-Biogene).
Library cloning and ﬁltering
The creation and validation of the pPAO10 phagemid
vector is extensively reported in Supplementary Figure 1
and Supplementary Data. Escherichia coli DH5F0,
F0/endA1 hsd17 (rK  mK+) supE44 thi-1 recA1 gyrA
(Nalr) relA1 _ (lacZYA-argF) U169 deoR (F80dlacD-
(lacZ)M15) strain was used. The pPAO10 phagemid
vector and the puriﬁed cDNA fragments (either pooled
HCC+HF, or HPI), with BssHII and NheI restriction
sites, were digested and ligated using T4 DNA ligase at
a molar ratio of 1:5. Totally 5mg of the ligated DNA were
transformed by electroporation into DH5aF0 bacteria,
which were then plated on 2xTY agar plates supplemented
with chloramphenicol (pPAO10 resistance, 34mg/ml) and
ampicillin (selective marker for ORFs, 15mg/ml) and
allowed to grow for 24h at 28 C. Dilutions were also
plated on either chloramphenicol/ampicillin or chloram-
phenicol alone to determine the library size. Bacteria were
collected, pooled, thoroughly mixed, supplemented with
20% sterile glycerol and stored at –80 C in small
aliquots. One aliquot immediately underwent the recom-
bination step yielding a standard phagemid construct for
display without b-lactamase as previously described (12).
Panning procedures
Production and rescue of phagemid particles was per-
formed as described elsewhere (24); the phages were
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tion of 10
12/ml. Selections on solid phase were performed
on Nunc Immunotubes coated with human recombinant
TG2 as described before (25). Selections on soluble TG2
were performed as follows: 10
12 phages diluted in 4% BSA
were mixed with biotinylated human recombinant TG2
and incubated for 30min in rotation followed by 30min
of static incubation at RT. Dynabeads MyOne
Streptavidin beads (Dynal Biotech ASA) were added to
human TG2-phages mix and panned in rotation for
45min at RT; the beads were then washed four and 12
times with PBS added with 0.1% Tween and four and 12
times with PBS for the ﬁrst and second round of selection,
respectively. Bound phages were eluted by adding 1ml of
E.coli DH5aF0,a tO D 600 0.5, at 37 C, for 45min, with
occasional shaking. Bacteria were plated on agar plates
added with chloramphenicol, grown O/N at 30 C, and
ﬁnally harvested and either grown immediately to
produce phages undergoing the following round of selec-
tion or stored in small aliquots at –80 C.
454 deep sequencing of cDNA inserts
An amount of 200ng cDNA fragments cut with BssHII
and NheI from the library were puriﬁed by MinElute
columns (Qiagen) in order to remove shorter fragments.
Ligation of the puriﬁed samples to speciﬁc adaptors and
preparation of the single strand libraries (sstDNA) were
performed following the manufacturer’s instruction
(Roche). The sstDNA libraries were quantitated by
RiboGreen RNA Quantitation Kit (Invitrogen) and
checked for quality by capillary electrophoresis (Agilent
Bioanalyzer 2100 with the RNA Pico 6000 LabChip kit;
Agilent Technologies). The sstDNA libraries were then
ampliﬁed in emulsion as required by the 454 sequencing
protocol. The reactions were recovered by isopropanol
emulsion breaking and enriched for positive reaction
beads. Each enriched sample was separately loaded onto
one-eighth of the PicoTiterPlate (PTP) and was sequenced
according to the 454 GS-FLX Titanium protocol.
Bioinformatic analysis
Sequences were processed with a custom analysis
workﬂow procedure mainly based on PERL scripts.
Both raw and analyzed data were stored in a relational
database. Brieﬂy, sequences were mapped onto the human
genome (NCBI build 36) using gmap software and
matching sequences were compared with annotated
genes. Each gene was then ranked according to the
number of supporting sequences. The ‘depth index’ for
each gene was deﬁned as the maximum number of
overlapping sequences (i.e. sequences supporting the
same genic region). The ‘focus index’—deﬁned as (depth
– 1)/rank—ranges between 0 (indicating a broad distribu-
tion of sequences over the gene) and 1 (indicating that all
sequences are ‘focused’ on the same region). Data are
accessible through a Web based interface (available at
http://www.interactomeataglance.org/) implemented in
php and java.
Cloning of selected cDNA fragments
After each selection, plasmid DNA was isolated from
colonies rescued from the plates. 0.1ng of each prepara-
tion was used as a template for the inverse PCR reaction.
A pair of speciﬁc primers was designed for each of the top
ranking genes, centering on the epitope region identiﬁed
by the overlapping reads. The forward primer was
synthesized with phosphorylated 50-end in order to allow
ligation of blunt ends and PCR was performed with a
Phusion High-Fidelity DNA Polymerase (Finnzymes)
according to the supplier’s protocol. After gel puriﬁcation,
the PCR product was ligated by T4 DNA ligase O/N at
16 C, and the ligation reaction transformed into DH5aF0
competent cells. Colonies obtained on chloramphenicol
plates were sequenced to assess the successful cloning of
speciﬁc gene fragments.
ELISA
Expression and testing of selected clones, either in the
phage format or as soluble polypeptides, for recognition
of human TG2 in ELISA was performed according to
standard protocols and as previously described (25).
Brieﬂy, phage ELISA was performed by coating Costar
ELISA strips with human and mouse recombinant TG2 or
BSA and WNT4 (as negative control) at 10mg/ml. Wells
were blocked with 2% MPBS and rinsed. Phages of indi-
vidual clones used in 1:1 dilution with 4% MPBS were
added to the wells, followed by HRP-conjugated
anti-M13 monoclonal antibody (Amersham Pharmacia).
The complexes were revealed with TMB (3,30,5,50-
tetramethylbenzidine) and read at A450. ELISA on
soluble TG2 was performed as follows: 10
12 phages of
individual clones diluted in 4% BSA were mixed with
biotinylated human recombinant TG2 and incubated for
30min in rotation followed by 30min of static incubation
at RT. Dynabeads MyOne Streptavidin beads (Dynal
Biotech ASA) were added to the human TG2-phage mix
and incubated in rotation for 45min at RT. After ﬁve
washes with PBST, HRP-conjugated anti-M13 mono-
clonal antibody (Amersham Pharmacia) was added for
45min. After ﬁve additional washes with PBST the
complexes were revealed with TMB and read at A450.
All experiments were performed in three replicates.
Cloning of interactors for PCA
Details for pa and px vector construction are described in
(26). The DNA fragments of interactors were cut from
pPAO10 with BssHII and NheI restriction enzymes, and
ligated into the px vector. Human TG2 was PCR
ampliﬁed from pTrcHis-htTG (25) with the forward
primer htTG-EcoRI (50-AGTCGGATCCGAATTCATG
GCCGAGGAGCTGGTC-30) and the reverse primer
htTG-HindIII (50-AGCTAAGCTTTTAGGCGGGGCC
AATGATG-30). The TG2 gene was digested with EcoRI
and HindIII, and ligated into the pa vector. As positive
control, co-transformed bacteria pa-RON2/px-sc7 were
used according to Secco et al. (26). px-G2 was used as
negative control for the interaction with TG2: G2 is a
scFv recognizing a portion of the Cholera toxin (DG).
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The DH5aF0 were co-transformed with both pa-TG2 and
px-interactor vectors. After incubation for 1h at 37 C
without selective pressure, the co-transformed cells were
plated onto 2xTY agar plates, supplemented with 50mg/ml
kanamycin and 34mg/ml chloramphenicol, and incubated
O/N at 30 C.
A single clone of each co-transformed bacteria was
grown in 2xTY broth, supplemented with 50mg/ml
kanamycin and 34mg/ml chloramphenicol, at 37 Ct o
OD600 0.5. Bacteria were plated either onto agar plate
supplemented with 50mg/ml kanamycin and 34mg/ml
chloramphenicol for titration, or onto plates supple-
mented with increasing ampicillin concentration (15–20–
30mg/ml) and 1mM IPTG. The plates were incubated at
28 C for 48h and bacterial growth was scored from
negative (–) to highly positive (+++).
RESULTS
Strategy
The overall strategy we have developed to identify the
TG2 interactome consists of four key steps as outlined
in Figure 1: (i) Generation of an ORF ﬁltered phage
display library. mRNA is fragmented into calibrated
lengths, reverse transcribed into cDNA, normalized,
cloned into the ﬁltering vector and clones encoding
ORFs are ﬁltered out using ampicillin selection. (ii)
Selection of interacting ORFs on a target protein. After
elimination of the b-lactamase-coding region by Cre-lox
mediated recombination, ORF displaying phages are
challenged with puriﬁed recombinant TG2 through two
cycles of selection and ampliﬁcation. (iii) Massive
sequencing of selected inserts and ranking of reads. cDNA
insert fragments are recovered from the selected libraries,
sequenced with 454 pyrosequencing and ranked according
to their frequency. (iv) Recovery and validation of the most
frequent ORFs. Highly scored ORFs are recloned from the
library by inverse PCR (27) and their interactions
validated by ELISA and the PCA .
Construction of phage display ORFs cDNA library
PolyA+ RNA was obtained from human colon carci-
noma cells (HCC), human lung ﬁbroblasts (HF) and
puriﬁed human pancreatic islets (HPI). mRNA samples
were fragmented with a calibrated length of 100–600
bases in order to improve the uniformity of sequence
coverage across transcripts (28). Orientated cDNA frag-
ments (23) were prepared by random primer reverse tran-
scription and normalization (22). Finally a cDNA display
library was created within the context of an improved
version of the pPAO2 phagemid vector (pPAO10, see
Supplementary Figure 1 and Supplementary Data).
After cDNA fragment ligation and transformation two
libraries of 9 10
6 and 2.1 10
7 clones were obtained
for pooled HCC+HF or HPI cDNAs, respectively. The
size of the libraries was reduced to 4 10
5 and 1.2 10
6,
respectively after ORF ﬁltering by ampicillin selection.
This corresponds to a reduction in clone numbers of
 95% (95.6% for HCC+LF and 94.3% for HPI) which
is in line with theoretical expectations as well as with
previous observations (12), and indicates that ORF ﬁltra-
tion was successful. On the basis of the observed numbers,
each library represents a potential of at least 40 ORF
fragments per gene, assuming that all 24000 human
genes are equally represented in the normalized cDNA.
Library characterization by massive sequencing
The two libraries were pooled (termed NS, for ‘not
selected’ library), cDNA fragments were recovered after
pooled phagemid digestion with BssHII and NheI restric-
tion enzymes and were subjected to 454 sequencing. We
obtained 67587 reads from the NS library (Table 1). These
were aligned to the human genome sequence (NCBI build
36) using gmap software. Totally 51071 sequences had at
least 95% identity and 90% overlap. 7576 genes were
identiﬁed by at least 1 read (Figure 2A) (complete data
at http://www.interactomeataglance.org) conﬁrming the
high diversity of the NS library. The eﬃcacy of cDNA
normalization was shown by the fact that 6259 (corre-
sponding to 83%) of the identiﬁed genes were represented
by no more than 10 reads in the library (Figure 2B).
In order to analyze the eﬃcacy of the ORF ﬁltration in
more detail we created a subset of so called ‘perfect
sequences’. These had no sequence diﬀerences compared
with the annotated genome sequence, and contained
vector encoded restriction sites at both ends, indicating
that they represented complete phage inserts. This was
considerably facilitated by the long reads we could
obtain with the 454 GS-FLX Titanium. Totally 12119
reads fulﬁlling the ‘perfect sequences’ requirements were
obtained. The length of 11060 of these (91.2 %) sequences
were multiples of 3bp, corresponding to ORFs in our ﬁl-
tering system and 99% of these contained no stop codons,
conﬁrming the quality of the ﬁltering procedure. Of those
containing stop codons, 67% were amber codons that are
suppressed in the DH5aF0 E.coli strain. Furthermore,
85% of these sequences mapped to the correct frame of
the gene, and consequently represented real genes rather
than spurious ORFs.
Library selection
ORF displaying phages were used for the selection of
interacting proteins using puriﬁed recombinant human
TG2 as the target. TG2 is a structurally complex
multi-domain enzyme, undergoing extensive conforma-
tional changes under diﬀerent physiological conditions
(29,30). In order to account for the possibility that TG2
may be denatured by solid-phase absorption (perhaps
leading to the binding of diﬀerent targets), selection was
carried out using two diﬀerent methods: in the ﬁrst the
library was challenged with solid phase immobilized
human TG2 (SP selection); in the second, soluble bio-
tinylated TG2 was used (BIO Selection). In the latter
case, after incubation with the phage library, the
biotinylated TG2 along with potential associated phages
was recovered after incubation with the phage library
using streptavidin-conjugated magnetic beads. Bound
phages were subsequently eluted with conventional
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output diversity (31) only two cycles of selection were per-
formed for both the SP and BIO proteins. Twenty random
colonies were checked after each selection: electrophoretic
analysis of insert sizes and subsequent restriction ﬁnger-
printing showed a substantial diversity of selected clones,
indicating that no single clone(s) dominated after the
selection (not shown).
Massive sequencing of selected inserts and
ranking of reads
After two selection rounds using TG2 that was either
directly immobilized (SP), or biotinylated (BIO), the
selected cDNA fragments were recovered by digesting
phagemid DNA with BssHII and NheI. The puriﬁed frag-
ments were used for 454 based sequencing, yielding 61863
(II-SP) and 60275 (II-BIO) diﬀerent reads (Table 1).
Compared with the not selected (NS) library, the diversity
after selection did not appear to be signiﬁcantly reduced,
in that sequences corresponding to over 7000 diﬀerent
genes for the two selections were matched by at least 1
read. However, this included a total of 3232 genes not
listed in the original non-selected data set, indicating
that the library diversity was even greater than that
described by the ﬁrst sequencing data set. Reads corre-
sponding to the not selected and the selected libraries
were mapped to the human genome and matched
regions were ranked on the basis of the total number of
reads obtained for every gene. The 50 genes found most
frequently in the not selected and the two selected libraries
(Supplementary Table S1) were further analyzed and
validated. Among these genes (Figure 3A) only three
were common to all three libraries and seven more to
the two selected ones, indicating that the two TG2 forms
Figure 1. Interactome discovery pipeline. Poly A
+ RNA is fragmented and retro-transcribed to cDNA by random priming. After normalization and
linker ligation cDNAs are cloned into pPAO10 ORF-ﬁltering vector and the library is ﬁltered on chloramphenicol/ampicillin containing plates. After
CRE-mediated recombination, ORF-displaying phages are challenged with TG2 throughout two cycles of selection and ampliﬁcation. The ORF
inserts of selected phages are obtained by digestion with restriction fragments and massively sequenced. Reads are mapped to the human genome and
identiﬁed genomic regions are ranked on the basis of read coverage. Clones containing candidate interacting ORFs are rescued from selected libraries
by inverse PCR using primers matching the contig sequence core. Recovered clones are expressed and validated by ELISA.
Table 1. Summary of reads obtained from 454 sequencing
NS II-BIO II-SP
Total numer of sequences 67587 60275 61863
Total with 50 45127 43097 37340
Total with 30 40663 39985 35224
Total with 50 and 30 27946 30541 24049
Average length 245 246 211
Reads mapping 51071 47393 43623
Genes 7576 7091 7524
Summary of reads obtained from 454 sequencing of not selected (NS)
and selected (BIO, SP) libraries. Number of total sequences, and of
sequences with vector encoded restriction site at one or both ends are
reported. Reads were deﬁned as mapping if aligned to the genome with
at least 95% identity and 90% overlap. Genes identiﬁed by at least one
read are reported.
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properties. Moreover, the diﬀering composition of the
two selections conﬁrms that selection did not appear to
be biased towards non-speciﬁc high frequency phage
clones. Interestingly, the top ﬁve genes for the immo-
bilized TG2 selection comprised only 4.9% of the total
number of reads, while for the biotinylated TG2, the top
ﬁve genes comprised 15.4% of reads, indicating that if 96
clones were picked at random for sequencing and/or
ELISA, according to standard techniques, the liklihood
of identifying all 10 of these clones would be very low.
This is represented in Figure 3B where the theoretical
chance [p(top)] of identifying the top ﬁve (or top 10)
clones identiﬁed using massive sequencing is plotted
versus the number of random picked clones that would
have to be assayed in order to identify the same top
ranking genes in a traditional system: to identify the top
ﬁve genes with 95% certainty, over 500 random clones
would have to be picked for each selection. The fact that
the two diﬀerent forms of TG2 selected diﬀerent
interactors may seem counterintuitive at ﬁrst sight.
However, this conﬁrms results we published using phage
Figure 3. (A) Venn diagram of the ﬁrst 50 genes on the ranking list of non selected (NS) and selected (BIO, SP) libraries. (B) Probability of
identifying all top ﬁve or top 10 genes by random selecting sample of clones of increasing size. Probability (pTop) has been approximated by a 10000
cycle simulation for each sample size (picked clones). Simulation was performed using a custom developed PERL script. (C) Focus indexes for the
ﬁrst 50 genes of each library ranked on the basis of the number of supporting reads (coverage). The horizontal bars represent the mean value.
Figure 2. (A) Rank abundance curve obtained by plotting the total number of mapped informative reads (presence of both 454 primers) versus the
total number of identiﬁed genes. (B) Chart shows how many genes are supported by diﬀerent number of reads. As a result of cDNA normalization
the vast majority of genes are represented by up to 10 reads while only very few genes show more reads (with a maximum of 680). X-axis has been
limited to 50.
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same antigen presented in diﬀerent formats could result
in the selection of diﬀerent antibodies (31).
In order to determine whether the sequencing data
could be used to provide information beyond gene identi-
ﬁcation, and identify domains within proteins that were
responsible for binding to TG2, we developed a ‘focus
index’ for each ranked gene. This represents the ratio
between the depth of read coverage at the deepest site
and the total number of reads per gene. The closer this
ratio is to one, the more ‘focused’ the reads are to a single
site or domain within the gene, while the lower the index,
the more widely distributed the reads are on each gene.
Figure 3C shows the focus index for the ﬁrst 50 genes of
each of the three libraries (NS, SP and BIO). It can be
clearly seen that reads from the unselected library have a
low focus index, indicating that these reads are distributed
throughout each of the identiﬁed genes, while reads
from the selected libraries have far higher focus indices,
indicating that speciﬁc interacting domains have been
selected (an example of such focussing is shown for
genes MYO18A and LAP3 in Supplementary Figure S2).
Interacting clones validation
In order to conﬁrm that the selection procedure really
identiﬁed TG2 protein-binding partners, clones corre-
sponding to the top ﬁve genes from each selection
(Table 2) were selected for further analysis. All sequences
were in the correct mRNA orientation and 7 out of 10
were in the correct reading frame, whereas two (SP-5
and BIO-4) were in reading frames 2 and 3, respectively,
thus completely altering the actual amino acid sequence.
These amino acid sequences were tested by protein
BLAST aligment and did not give any signiﬁcant
homology to known proteins. The tenth clone (SP-4) is a
non-protein-coding transcript which however in this
context encodes for an ORF. The corresponding gene is
reported in Table 2 only for reference. Clones were
recovered from the corresponding selected library by
inverse PCR (27) using a pair of speciﬁc primers centering
on the region identiﬁed by the overlapping reads. After
cloning, one to three diﬀerent sequences were recovered
for each of the 10 top scoring clones. After validation by
sequencing, one clone for each interacting protein was
selected for further analysis. cDNA fragments were
expressed on the phage surface and analyzed for TG2 rec-
ognition by ELISA. All ten clones were tested by ELISA
using both human and mouse TG2 as well as two
unrelated control proteins (BSA and WNT4) in both
solid phase and as soluble antigen. As shown in
Figure 4A 9 of the 10 clones showed a positive signal
with human TG2 (but not with the control proteins)
when tested in solid phase ELISA. Interestingly, the
speciﬁcity of the binding was also conﬁrmed using
recombinant mouse TG2; all cDNA fragments tested,
Table 2. Description of the ELISA-validated top ﬁve ranking clones from the selected libraries
Code Gene name and frame Hugo Accession number First base Length (bp)
SP selected clones
SP-1 Leucine aminopeptidase 3, frame 1 LAP3 NM_015907.2 1078 186
SP-2 Glutathione S-transferase omega 2, frame 1 GSTO2 NM_183239.1 623 177
SP-3 Fibronectin 1, transcript variant 1, frame 1 FN1 NM_212482.1 1581 390
SP-4 H19, imprinted maternally expressed transcript
(non-protein coding)
H19 NR_002196.1 50 114
SP-5 Heat shock 70kDa protein 1A, frame 2 HSPA1A NM_005345.4 1343 396
BIO selected clones
BIO-1 Aldolase B, fructose-bisphosphate, frame 1 ALDOB NM_000035.2 126 354
BIO-2 Tetratricopeptide repeat domain 31, frame 1 TTC31 NM_022492.4 311 330
BIO-3 SPARC related modular calcium binding 1, frame 1 SMOC1 NM_022137.4 1139 408
BIO-4 Zinc ﬁnger protein 23 (KOX 16), frame 3 ZNF23 NM_145911.1 1728 498
BIO-5 Myosin XVIIIA, frame 1 MYO18A NM_078471.3 4956 291
Top ﬁve ranking clones from each selection. Ranking is based on the number of reads. Name, frame, abbreviation, accession number, ﬁrst base of
the gene fragment, as well as length of the clone is reported.
Figure 4. ELISA reactivity of the top ﬁve clones from BIO and SP
selection. Reactivity was tested on recombinant human and mouse
TG2 proteins and on negative control proteins (BSA and WNT4)
coated on solid surface (A) and as soluble biotinylated proteins (B).
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protein. The same clones were also positive when tested
on the soluble antigens (Figure 4B), further conﬁrming the
speciﬁcity of the interaction.
Phage display of polypeptides is a reliable method for
the identiﬁcation of antigens and binding structures.
Although it is considered to be highly speciﬁc, it generally
requires conﬁrmation of the binding using alternative
methods. In our case, we used the PCA, a method
previously used in our laboratory (26). All the selected
TG2 interactors were cloned into the po vector, in
frame with the C-terminal fragment (aa 196–286) of
TEM-1 b-lactamase, while the human TG2 gene
was cloned into the pa vector, fused to the a fragment
(aa 1–195, N-terminal). The rationale of the system is
that when the two partners interact, b-lactamase activity
is reconstituted and the clone gains resistance to
ampicillin. Once a stable bacterial clone expressing TG2
in the pa context was obtained, it was transformed with
plasmids encoding the individual interactors expressed in
the po vector. The resulting clones, with resistance to both
chloramphenicol and kanamycin (encoded in the back-
bones of the two plasmids), were challenged with
increasing amounts of ampicillin, ranging from 15mg/ml
to 30mg/ml. The growth at each concentration was scored
and reported on a semiquantitative scale ranging from
negative (–) to very positive (+++). The results are
summarized in Table 3. Speciﬁcity of interaction for
TG2 was conﬁrmed as most of the clones grew well even
at the highest ampicillin concentration, and did not grow
when tested against an unrelated target at the lowest
ampicillin concentration. Two of the clones (SP-4 and
BIO-3) grew slowly at higher ampicillin concentrations,
while two (BIO-1 and BIO-4) did not grow at all on
ampicillin. Of these four clones, SP-4 and BIO-4 were
derived from ORFs that were in a diﬀerent frame to
that of the annotated gene.
DISCUSSION
Over one thousand scientiﬁc reports related to TG2 have
been published in the past ﬁve years, attesting to the
growing interest in this enzyme. Although belonging to a
well-known family of enzymes and being itself an
extensively studied molecule, the biological signiﬁcance
of TG2 and its enzymatic functions are still far from
completely elucidated, mainly due to the many diﬀerent
biological functions in which it is thought to be involved.
The enzyme substrate speciﬁcity, and as many as 138
targets substrates, have been identiﬁed to date using a
number of diﬀerent techniques including phage display
(33–35; listed in the TRANSDAB online database
http://genomics.dote.hu/wiki/; 36). In contrast, only a
limited number of interaction partners has been identiﬁed
and experimentally validated: only nine partners are
present in the same TRANSDAB database. It is therefore
clear that an approach attempting to systematically
identify TG2 protein-binding partners is very much
needed, and the present study provides a ﬁrst step in this
direction. Within a more general context, TG2 is only one
of many proteins with very complex interaction networks,
the characterization of which requires appropriate tools
that allow the screening of a large number of potential
interacting partners. In the present work, we show that
by using massive sequencing in combination with phage
display cDNA libraries, we are able to increase the
number of screened clones by at least two orders of mag-
nitude compared with a typical ELISA-based screen
employing microtiter plates. In such a conventional
strategy only a few hundred clones are assayed, whereas
here we report more than 60000 sequences, with the the-
oretical upper limit restricted only by the capacity of the
sequencing system. Despite replacing a relatively cheap
assay (ELISA) with a more expensive one (massive
sequencing) may seem a major drawback, several impor-
tant details should be considered. First, the amount of
information obtained by massive sequencing far exceeds
that which can be obtained by traditional screening.
Second, positive clones identiﬁed by ELISA still need
identiﬁcation by standard sequencing, and the number
of required sequences can be very high when the binders
of interest are many and a few clones are over-represented.
Thirdly, massive sequencing provides a ranking of the
most frequently selected clones, with the number of
times each is selected. In Figure 3B, we have carried out
a simulation of the chance of identifying the top ﬁve (or
10) clones identiﬁed using massive sequencing for a
speciﬁc number of picked clones. For example, if 100
clones for each selection were picked at random, the
chance that the top ranked ﬁve clones for each selection
would be picked is 30% for the BIO selection and 13% for
the SP selection (and essentially zero for the top ten
clones). In fact, one would have to pick 1000 clones to
have a 99% chance of picking the top ﬁve clones in both
selections. In this article we carried out analysis after two
rounds of selection, which gives the best balance between
high numbers of positive clones and broad diversity.
However, given the great analytical potential of this
method, it may be possible to carry out analysis after a
Table 3. Validation of selected clones by PCA assay
TG2 Negative
Control
Cam/
Kan
15Amp 20 Amp 30 Amp 15 Amp
BIO-1 + – – – –
BIO-2 + +++ +++ +++ –
BIO-3 + ++ + + –
BIO-4 + +/– – – –
BIO-5 + +++ +++ +++ –
SP-1 + +++ +++ +++ –
SP-2 + +++ +++ +++ –
SP-3 + +++ +++ +++ –
SP-4 + ++ + + –
SP-5 + +++ +++ +++ ––
Positive control + +++ +++ +++ +
Negative control + – – – –
In vivo validation of selected interactors. E. coli cells containing the
pa-TG2 vector were transformed with the px vector carrying the
cloned interactors. Bacteria were plated on plates supplemented with
kanamicin/chloramphenicol to check the presence of both vectors, and
on plates supplemented with increasing ampicillin concentration (15
to 20 to 30mg/ml) and IPTG 1mM to assay interaction. Positive and
negative controls are described in the ‘Materials and Methods’ section.
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clones by direct comparison to the unselected library. This
is likely to identify signiﬁcantly more potential interacting
partners than could ever be analyzed using the traditional
approach.
Finally, by virtue of the extremely deep sequencing that
is carried out, in addition to providing information on
interacting proteins, this method also identiﬁes the
domains responsible for the interactions directly in a
ﬁrst screen. Such detailed information on the interaction
domains would not be possible using traditional methods,
where little more than the identiﬁcation of the interacting
gene would be expected to be obtained, and following such
identiﬁcation, new libraries would have to be created for
each protein in order to identify the responsible interact-
ing domain.
Although the costs of 454 sequencing are relatively high
at the moment, greater availability is likely to lead to a
reduction in price, and as barcoding becomes more sophis-
ticated, multiplexed analysis will become more straightfor-
ward, allowing broader screening, and the proﬁling of the
interactomes of several players involved in a biological
process simultaneously. In this study we conﬁrmed the
reliability of the b-lactamase based selection system to
select ORFs. We have shown that over 91% of clones
ﬁltered using this system comprise ORFs representing
multiples of 3nt that lack non-suppressible stop codons.
Seven out of the ten top ranking sequences identiﬁed
were derived from the correct frame. In general, cloned
sequences not expressed in the correct frame but neverthe-
less recognized by a reactant (e.g. in immunorecognition)
are described as mimotopes; i.e. random polypeptides
whose structures resemble those of other proteins
normally recognized by the selector. These two clones
were conﬁrmed as being mimotopes after they were
recloned with the addition of an extra base to allow trans-
lation in frame 1. The subsequent ELISA analysis (not
shown) revealed a loss in recognition by both human
and mouse TG2, indicating that the polypeptide translated
in the annotated frame does not interact with TG2.
Of the identiﬁed genes, three have been previously
reported as either directly interacting with TG2, or as
belonging to a family of proteins, a member of which
has been identiﬁed as interacting with TG2. Fibronectin
(FN1) (Table 2, clone SP-3) has been described as inter-
acting with TG2 (36), and has been extensively studied for
its implication in TG2 mediated cell adhesion to the
extracellular matrix (37). Fibronectin was third in the
ranking of the solid phase selection with 685 sequences,
and 23rd in the BIO selection with 181 sequences. When
all these sequences were aligned we were not only able to
conﬁrm the region previously proposed for TG2 interac-
tion (37), but to further restrict the size from a relatively
large 42-kDa fragment to one of only 130 aa, thus con-
ﬁrming the value of obtaining multiple sequences for each
interacting protein. Secreted modular calcium-binding
(SMOC1) (Table 2, clone BIO-3) is a member of the
BM-40/SPARC family of matricellular proteins thought
to inﬂuence growth factor signaling, migration, prolifera-
tion, and angiogenesis (38). SPARC was identiﬁed as a
TG2 interacting partner using Y2H in a proteome-scale
map of the human protein–protein interaction network
(39). Finally glutathione S-transferase omega 2 (GSTO2)
(Table 2, clone SP2), is part of a family of enzymes that
play an important role in detoxiﬁcation by catalyzing the
conjugation of many hydrophobic and electrophilic
compounds with reduced glutathione. Glutathione
S-transferase P was identiﬁed as a TG2-binding partner
in immunoprecipitation experiments (40). Although TG2
is found mainly in the cytoplasm, it is also found in the
nucleus, plasma membrane, and the extracellular matrix,
making it diﬃcult to use cellular co-localization as conﬁr-
matory information in this speciﬁc case.
On this basis, the other proteins may be considered to
belong to a novel class of putative TG2 interacting
partners that could be added to the fast-growing TG2
TRANSDAB database (35). Furthermore, a more
detailed analysis of many of the other selected gene frag-
ments will likely identify many other potential interaction
partners.
In conclusion, by using this cDNA fragment phage
display library, we have shown the power that the appli-
cation of massive 454 deep sequencing can bring to library
analysis, and in particular, as it relates to the analysis of
protein–protein interactions. In fact, further conﬁrmation
of the results described here may allow the replacement of
protein expression and ELISA testing for protein–protein
interactions with massive deep sequencing. We anticipate
that this approach to library and selection analysis can
also be extended to the other methods traditionally used
to study protein–protein interactions (i.e. PCA and Y2H)
as well as to the study of the selection of peptides and
antibodies by phage display. Furthermore, beyond the
identiﬁcation of proteins involved in interactions, the use
of libraries of fragmented genes as described here also
localizes the regions of interactions to domains, rendering
the information more useful.
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